OxLDL-CD69 binding triggers a protective effect, enhancing the anti-inflammatory transcription factors NR4A1 and NR4A3 (NOR-1), downregulating proinflammatory cytokines and promoting Treg differentiation, thereby modulating atherosclerosis [9]. Here, CD69 is linked to atherosclerosis.